115 related articles for article (PubMed ID: 4757978)
1. [Letter: Relative estrogen deficiency caused by contraceptives].
Bailer P
Dtsch Med Wochenschr; 1973 Nov; 98(45):2162. PubMed ID: 4757978
[TBL] [Abstract][Full Text] [Related]
2. Estrogens in oral contraceptives: historical perspectives.
Goldzieher JW
Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
[TBL] [Abstract][Full Text] [Related]
3. [Effects and side-effects of 2 estrogen-lynesterenol combinations used in hormonal ovulation inhibition].
Jacobs C; Heinen G; Schmal E
Med Welt; 1974 Sep; 25(35):1351-3. PubMed ID: 4419263
[No Abstract] [Full Text] [Related]
4. [Rationale for prescribing oral contraceptives].
Teichmann AT
Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
[TBL] [Abstract][Full Text] [Related]
5. Oral contraception.
Helles AA
Arch Pharm Chem (Kbh); 1971; 78():2-9. PubMed ID: 12334380
[TBL] [Abstract][Full Text] [Related]
6. The effect of the phase of the menstrual cycle and the birth control pill on athletic performance.
Lebrun CM
Clin Sports Med; 1994 Apr; 13(2):419-41. PubMed ID: 8013042
[TBL] [Abstract][Full Text] [Related]
7. Formulation and noncontraceptive uses of the new, low-dose oral contraceptive.
Batzer FR
J Reprod Med; 1984 Jul; 29(7 Suppl):503-12. PubMed ID: 6237195
[TBL] [Abstract][Full Text] [Related]
8. [Hormonal contraception--side effects and surgical aspects (author's transl)].
Göretzlehner G; Carol W; Köhler G
Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744
[TBL] [Abstract][Full Text] [Related]
9. A new progestogen-estrogen combination for gynecologic therapy and contraception.
Linthorst G
Int J Fertil; 1966; 11(1):35-45. PubMed ID: 5936282
[No Abstract] [Full Text] [Related]
10. [Advantages and risks of hormonal contraception].
Mall-Haefeli M
Fortschr Med; 1982 Apr; 100(16):723-8. PubMed ID: 7084860
[TBL] [Abstract][Full Text] [Related]
11. Present status of oral contraceptives: 1. effectiveness; basis for selection; side effects; metabolic changes.
Kistner RW
Drug Ther (NY); 1971 Dec; 1(12):14-29. PubMed ID: 12306285
[TBL] [Abstract][Full Text] [Related]
12. Current perspectives on combination oral contraceptives.
Smith MA; Youngkin EQ
Clin Pharm; 1984; 3(5):485-96. PubMed ID: 6386284
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptives.
Maclennan AH
Curr Ther (Seaforth); 1987 Dec; 28(12):113-22. PubMed ID: 12317413
[TBL] [Abstract][Full Text] [Related]
14. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
15. [Clinical experiences with gestagen therapy of various gynecologic diseases].
György G; László J
Orv Hetil; 1967 Jun; 108(25):1169-71. PubMed ID: 6077686
[No Abstract] [Full Text] [Related]
16. [Oral contraception: failures and risks].
Foussard-blanpin O; Paillot-renaud P; Bruneau-bigot A
Lyon Pharm; 1984 Nov; 35(6):385-93. PubMed ID: 12280590
[TBL] [Abstract][Full Text] [Related]
17. [Supraventricular arrhythmia caused by ovulation inhibitors?].
Lauritzen C
Dtsch Med Wochenschr; 1979 Apr; 104(17):613. PubMed ID: 436642
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of ethinylestrenol and mestranol as a contraceptive.
Kaltreider DF
Fertil Steril; 1968; 19(4):589-92. PubMed ID: 5660243
[No Abstract] [Full Text] [Related]
19. Effectivity and acceptability of oral contraceptives containing natural and artificial estrogens in combination with a gestagen. A controlled double-blind investigation.
Serup J; Bostofte E; Larsen S; Westergaard J
Acta Obstet Gynecol Scand; 1981; 60(2):203-6. PubMed ID: 7018165
[TBL] [Abstract][Full Text] [Related]
20. Lyndiol: evaluation of safety and efficacy as an oral contraceptive.
Strade HA
Curr Ther Res Clin Exp; 1966 May; 8(5):265-79. PubMed ID: 4956390
[No Abstract] [Full Text] [Related]
[Next] [New Search]